Literature DB >> 8531327

[Acquired amylase production induced by radiotherapy in a myeloma patient].

T Yamakawa1, H Nagoshi, A Takahashi, R Fukumura, S Takahashi, M Nomura, H Isobe, K Ide, T Ayabe, S Shimizu.   

Abstract

A 55-year-old patient with multiple myeloma (IgG-lambda) diagnosed in November 1988 was admitted because of bone pain throughout the body. After plasmapheresis and several courses of chemotherapy, a massive tumor of the left thoracic wall involving the rib appeared. Radiotherapy was performed to ameliorate the severe chest pain, after which myelomatous pleural effusion appeared on the left side. The serum, urine and pleural effusion revealed increased activity of amylase of the salivary type. Amylase activity was also detected in the supernatant of myeloma cells cultured from pleural effusion. We reviewed 12 cases of ectopic amylase-producing multiple myeloma. All the cases except one have been reported from Japan, and hyperamylasemia in these cases was detected at diagnosis or during course of the illness. Moreover, cytogenetic analysis of myeloma cells of previous reports revealed structural abnormalities including chromosome 1, near the amylase gene locus. This case also showed t (1; 10) (q 21?; q 26) by examination of 8 metaphase derived from bone marrow. These observations suggested that ectopic amylase production was induced by irradiation to the plasmacytoma of thoracic wall.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531327

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  2 in total

1.  Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemia.

Authors:  S Nair; P Sachan; H Hertan; C S Pitchumoni
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

2.  A case report of a salivary amylase secreting plasmacytoma in a patient with multiple myeloma.

Authors:  Serena L Harborne; Rachael Curley; David W Bullimore; Dominic Chan-Lam; Jean-Pierre Ng; Philip T McAndrew
Journal:  BMJ Case Rep       Date:  2009-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.